2025-05-02 19:23:32
Latest Post
SIS Ltd sinks to Q4FY25 consolidated loss of Rs. 223.35 crores
Eternal Ltd posts fall in Q4FY25 consolidated PAT to Rs. 39 crores
Adani Ports and Special Economic Zone Ltd Q4 FY2024-25 consolidated net profit rises to Rs. 3014.22 crores
Wardwizard Innovations and Mobility Ltd consolidated Q4 FY25 PAT increases to Rs. 6.44 crores
Indus Towers Ltd Q4 FY2025 consolidated profit drops to Rs. 1779.1 crores
Stock Report
JB Chemicals and Pharmaceuticals Q3 FY2021-22 consolidated net profit falls to Rs. 83.88 crores
Posted On : 2022-02-17 11:42:43( TIMEZONE : IST )
JB Chemicals & Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 605.1838 crores during the period ended December 31, 2021 as compared to Rs. 612.6558 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 83.8860 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 97.7531 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 10.82 for the period ended December 31, 2021 as compared to Rs. 12.63 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 605.1838 crs | ₹612.6558 crs |  -1.22% |
| Net Profit | ₹83.8860 crs | ₹97.7531 crs | -14.19% |
| EPS | ₹10.82 | ₹12.63 | -14.33% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 605.1838 crores during the period ended December 31, 2021 as compared to Rs.604.1694 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.83.8860 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.154.1066 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.10.82 for the period ended December 31, 2021 as compared to Rs.19.94 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 605.1838 crs | ₹604.1694 crs |  0.17% |
| Net Profit | ₹83.8860 crs | ₹154.1066 crs | -45.57% |
| EPS | ₹10.82 | ₹19.94 | -45.74% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1836.8023 crores during the 9 Months period ended December 31, 2021 as compared to Rs.1601.1010 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.300.5123 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.347.3510 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.38.80 for the 9 Months period ended December 31, 2021 as compared to Rs.44.95 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹1836.8023 crs | ₹1601.1010 crs | 14.72% |
| Net Profit | ₹300.5123 crs | ₹347.3510 crs | -13.48% |
| EPS | ₹38.80 | ₹44.95 | -13.68% |
Shares of JB Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 1688.40 as compared to the previous close of Rs. 1619.20. The total number of shares traded during the day was 7192 in over 1578 trades.
The stock hit an intraday high of Rs. 1729.90 and intraday low of 1636.60. The net turnover during the day was Rs. 12152158.00.
